prometheus biosciences acquisition：Merck inks $11B Prometheus buyout to rival Roivant in IBD ...
Merck inks $11B Prometheus buyout to rival Roivant in IBD ...
2023年4月17日—Merck&Co.ispaying$10.8billiontobuyPrometheusBiosciencesforitslate-phaseboweldiseasedrugcandidate.。其他文章還包含有：「MerckCompletesAcquisitionofPrometheusBiosciences」、「MerckCompletesAcquisitionofPrometheusBiosciences」、「MerckFinalizes$10.8BPrometheusBuy」、「MerckStrengthensImmunologyPipelinewithAcquisitionof...」、「MercktobuyPrometheusBiosciencesforabout$11billion」、「M...
查看更多 離開網站
Merck Completes Acquisition of Prometheus Biosciences
https://www.merck.com
Under the terms of the acquisition agreement, Merck, through a subsidiary, has acquired all outstanding shares of Prometheus for $200.00 per ...
Merck Completes Acquisition of Prometheus Biosciences
https://merck2016rd.q4web.com
Under the terms of the acquisition agreement, Merck, through a subsidiary, has acquired all outstanding shares of Prometheus for $200.00 per ...
Merck Finalizes $10.8B Prometheus Buy
https://www.biospace.com
Merck finalized its acquisition of immune-focused Prometheus Biosciences for approximately $10.8 billion, scoring five clinical and pre ...
Merck Strengthens Immunology Pipeline with Acquisition of ...
https://www.merck.com
Under the terms of the acquisition agreement, Merck, through a subsidiary, will acquire all of the outstanding shares of Prometheus. The ...
Merck to buy Prometheus Biosciences for about $11 billion
https://www.reuters.com
N) said on Sunday it will buy Prometheus Biosciences Inc (RXDX.O) for about $10.8 billion, picking up a promising experimental treatment for ...
MSD Completes Acquisition of Prometheus Biosciences
https://www.msd.com
Under the terms of the acquisition agreement, MSD, through a subsidiary, has acquired all outstanding shares of Prometheus for $200.00 per share ...